In addition, we believe that some of our new share gain initiatives begun to take hold. By share gain initiatives, I'm referring to our focus on arming our commercial teams with the best products, targeting our sales efforts with the greatest opportunities and then converting those opportunities into revenues by closing sales. Specific examples include our Q Exactive launch, adding new HPLC capabilities from Dionex and leveraging our channels to drive sales of our specialty diagnostic products.
Thermo Fisher Scientific's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts